Trial Profile
Estimate of Costs Associated With Atrial Fibrillation Treatment With Rivaroxaban Versus Vitamin K Antagonists
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Acenocoumarol; Warfarin
- Indications Stroke
- Focus Therapeutic Use
- Sponsors Bayer
- 14 Mar 2018 New trial record